Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid

Journal of Cystic Fibrosis

Volumn 7, Issue 5, 2008, Pages 352-358

  MacGregor, Gordon ^a   Gray, Robert D ^a   Hilliard, Thomas N ^b   Imrie, Margaret ^a   Boyd, A Christopher ^a   Alton, Eric W F W ^b   Bush, Andrew ^b   Davies, Jane C ^b   Innes, J Alastair ^a   Porteous, David J ^a   Greening, Andrew P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bronchoscopy; Paediatric; Proteomics; Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; CALGRANULIN C; INTERLEUKIN 8;

ARTICLE; BRONCHOSCOPY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; GEL ELECTROPHORESIS; HUMAN; HYDROPHOBICITY; LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NEUTROPHIL COUNT; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RESPIRATORY TRACT DISEASE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 51349144874     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2007.12.005     Document Type: Article

References (28)

1. Rosenstein B.J., and Zeitlin P.L. Cystic fibrosis. Lancet 351 9098 (1998) 277-282
2. Armstrong D.S., Grimwood K., Carlin J.B., Carzino R., Gutierrez J.P., Hull J., et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156 4 Pt 1 (1997) 1197-1204
3. Alton E.W., Stern M., Farley R., Jaffe A., Chadwick S.L., Phillips J., et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353 9157 (1999) 947-954
4. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 7 13 (2000) 1156-1165
5. Porteous D.J., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4 3 (1997) 210-218
6. Ho L.P., Innes J.A., and Greening A.P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 53 8 (1998) 680-684
7. Ho L.P., Faccenda J., Innes J.A., and Greening A.P. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 13 1 (1999) 103-106
8. Tate S., MacGregor G., Davis M., Innes J.A., and Greening A.P. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57 11 (2002) 926-929
9. Sloane A.J., Lindner R.A., Prasad S.S., Sebastian L.T., Pedersen S.K., Robinson M., et al. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med 172 11 (2005) 1416-1426
10. Merkel D., Rist W., Seither P., Weith A., and Lenter M.C. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 5 11 (2005) 2972-2980
11. Kriegova E., Melle C., Kolek V., Hutyrova B., Mrazek F., Bleul A., et al. Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 173 10 (2006) 1145-1154 10.1164/rccm.200507-1126OC
12. McMorran B.J., Patat S.A., Carlin J.B., Grimwood K., Jones A., Armstrong D.S., et al. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem 53 10 (2007) 1782-1791
13. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 9306 (2002) 572-577
14. Rogers M.A., Clarke P., Noble J., Munro N.P., Paul A., Selby P.J., et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 63 20 (2003) 6971-6983
15. Agranoff D., Fernandez-Reyes D., Papadopoulos M.C., Rojas S.A., Herbster M., Loosemore A., et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368 9540 (2006) 1012-1021
16. McMorran B.J., Ouvry Patat S.A., Carlin J.B., Grimwood K., Jones A., Armstrong D.S., et al. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem 53 10 (2007) 1782-1791
17. Dorin J.R., Novak M., Hill R.E., Brock D.J., Secher D.S., and van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 326 6113 (1987) 614-617
18. van Heyningen V., and Dorin J. Possible role for two calcium-binding proteins of the S-100 family, co-expressed in granulocytes and certain epithelia. Adv Exp Med Biol 269 (1990) 139-143
19. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 7 (1999) 889-901
20. Gebhardt C., Breitenbach U., Tuckermann J.P., Dittrich B.T., Richter K.H., and Angel P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene 21 27 (2002) 4266-4276
21. Newton R.A., and Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160 3 (1998) 1427-1435
22. Golden B.E., Clohessy P.A., Russell G., and Fagerhol M.K. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 74 2 (1996) 136-139
23. Pearl D.C. Proteomic patterns in serum and identification of ovarian cancer. Lancet 360 9327 (2002) 169-170 author reply 170-1
24. Rockhill B. Proteomic patterns in serum and identification of ovarian cancer. Lancet 360 9327 (2002) 169 author reply 170-1
25. Baggerly K.A., Morris J.S., and Coombes K.R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20 5 (2004) 777-785
26. Elwood M. Proteomic patterns in serum and identification of ovarian cancer. Lancet 360 9327 (2002) 170 author reply 170-1
27. Schaub S., Wilkins J., Weiler T., Sangster K., Rush D., and Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65 1 (2004) 323-332
28. Schipper R., Loof A., de Groot J., Harthoorn L., Dransfield E., and van Heerde W. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. J Chromatogr B Analyt Technol Biomed Life Sci 847 1 (2007) 45-53